# US 2015/0174273 A1 · Imaging and therapeutic methods for treating parathyroid tumors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0174273 A1
- Document ID: US20150174273A1
- Status: Published application
- Kind: A1
- Application number: 14/416,694
- Filed: 2013-07-24
- Published: 2015-06-25
- Earliest claimed: 2012-07-25
- Assignees: Emory University
- Applicants: Emory University
- Inventors: Collin J. Weber
- Web page: https://patentgrep.com/patent/US20150174273A1

## CPC

- A61K 51/0459: {having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine}
- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- A61B 6/037: {Emission tomography}
- A61B 6/4057: {by using radiation sources located in the interior of the body (A61B6/037 takes precedence)}
- A61K 49/1833: {having a (super)(para)magnetic core coated or functionalised with a small organic molecule (oligomeric, polymeric, dendrimeric A61K49/1851)}
- A61K 51/0402: {carboxylic acid carriers, fatty acids (amino acids A61K51/0406)}
- A61K 51/0406: {Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines}
- A61K 51/0497: {conjugates with a carrier being an organic compounds}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

It has been discovered that human parathyroid tumor cells express high densities of folate receptors which could provide a target that may be used for localization. In certain embodiments, the disclosure relates to methods of detecting and imaging parathyroid tumors or canccrous cells in tissues using a folatc conjugate to enhance imaging techniques such as magnetic resonance imaging, positron emission tomography, computed tomography (CT), and single-photon emission computed tomography (SPECT). An image of radioactivities or nuclear magnetic resonance frequencies as a function of location for parcels (voxels), may be constructed and plotted. The image shows the tissues in which the tracer has become concentrated.

## Claims

### Claim 1

A method comprising
a) administering a metal particle-folate-conjugate to a subject at risk of, suspected of, or diagnosed with a parathyroid tumor;
b) exposing an area suspected of containing the parathyroid tumor of the subject to a magnetic field and a radio frequency pulse; and
c) detecting nuclear resonance frequencies in the area.

### Claim 2 (depends on 1)

The method of claim 1 further comprising the step of creating an image from the detected nuclear resonance frequencies.

### Claim 3 (depends on 1)

The method of claim 1 wherein the metal particle is an iron oxide nanoparticle.

### Claim 4

A method comprising
a) administering a radioisotope-folate conjugate to a subject at risk of, suspected of, or diagnosed with a parathyroid tumor, and
b) detecting gamma rays in an area of the subject.

### Claim 5 (depends on 3)

The method of claim 3 further comprising the step of creating an image from the detected gamma rays.

### Claim 6 (depends on 4)

The method of claim 4 wherein the radioisotope is 99mtechnetium.

### Claim 7

A method comprising
a) administering a composition comprising a positron-emitting radionuclide to a subject at risk of, suspected of, or diagnosed with a parathyroid tumor, and
b) detecting photons moving in approximately opposite directions in an area of the subject.

### Claim 8 (depends on 4)

The method of claim 4 further comprising creating an image from the detected photons.

### Claim 9 (depends on 7)

The method of claim 7 wherein the a positron-emitting radionuclide is anti-1-amino-[18F]flurocyclobutane-1-carboxylic acid (anti-18F-FACBC).
